Opendata, web and dolomites

IL7sigNETure SIGNED

IL-7/IL-7R signaling networks in health and malignancy

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 IL7sigNETure project word cloud

Explore the words cloud of the IL7sigNETure project. It provides you a very rough idea of what is the project "IL7sigNETure" about.

aggressive    landscape    data    therapeutic    fundamental    acute    fine    molecule    il7r    centered    models    regulation    arsenal    biology    extraordinary    levels    insights    limited    single    gained    mutations    cell    strategy    lung    chronic    molecular    function    tuned    hiv    showed    despite    transformation    once    patients    mechanisms    intervention    signaling    networks    effectors    sclerosis    network    normal    receptor    breast    full    profound    hematological    autoimmunity    view    characterization    platform    scope    reveal    employ    experimentation    interleukin    move    downstream    infection    therapies    holistic    display    activation    gaining    constitute    wired    promotes    cancer    multiple    extend    cells    gain    tumor    overcome    transduction    implicated    informing    complemented    pathological    relevance    leukemia    illuminate    inflammation    generate    cancers    settings    signal    rheumatoid    deregulation    vivo    complementary    throughput    multidisciplinary    axis    lymphoblastic    il7    arthritis    biological   

Project "IL7sigNETure" data sheet

The following table provides information about the project.

Coordinator
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES 

Organization address
address: AVENIDA PROF EGAS MONIZ
city: LISBOA
postcode: 1649 028
website: www.imm.ul.pt

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Portugal [PT]
 Project website https://imm.medicina.ulisboa.pt/en/investigacao/labs/barata-joao-t-lab/
 Total cost 1˙988˙125 €
 EC max contribution 1˙988˙125 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2014-CoG
 Funding Scheme ERC-COG
 Starting year 2015
 Duration (year-month-day) from 2015-09-01   to  2020-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES PT (LISBOA) coordinator 1˙988˙125.00

Map

 Project objective

Deregulation of signal transduction is a feature of tumor cells and signaling therapies are gaining importance in the growing arsenal against cancer. However, their full potential can only be achieved once we overcome the limited knowledge on how signaling networks are wired in cancer cells. Interleukin 7 (IL7) and its receptor (IL7R) are essential for normal T-cell development and function. However, they can also promote autoimmunity, chronic inflammation and cancer. We showed that patients with T-cell acute lymphoblastic leukemia (T-ALL), an aggressive hematological cancer, can display IL7R gain-of-function mutations leading to downstream signaling activation and cell transformation. Despite the biological relevance of IL7 and IL7R, the characterization of their signaling effectors remains limited. Here, we propose to move from the single molecule/pathway-centered analysis that has characterized the research on IL7/IL7R signaling, into a ‘holistic’ view of the IL7/IL7R signaling landscape. To do so, we will employ a multidisciplinary strategy, in which data from complementary high throughput analyses, informing on different levels of regulation of the IL7/IL7R signaling network, will be integrated via a systems biology approach, and complemented by cell and molecular biology experimentation and state-of-the-art in vivo models. The knowledge we will generate should have a profound impact on the understanding of the fundamental mechanisms by which IL7/IL7R signaling promotes leukemia and reveal novel targets for fine-tuned therapeutic intervention in T-ALL. Moreover, the scope of insights gained should extend beyond leukemia. Our in-depth, systems-level characterization of IL7/IL7R signaling will constitute a platform with extraordinary potential to illuminate the molecular role of the IL7/IL7R axis in other cancers (e.g. breast and lung) and pathological settings where IL7 has been implicated, such as HIV infection, multiple sclerosis and rheumatoid arthritis.

 Publications

year authors and title journal last update
List of publications.
2017 F Buontempo, J A McCubrey, E Orsini, M Ruzzene, A Cappellini, A Lonetti, C Evangelisti, F Chiarini, C Evangelisti, J T Barata, A M Martelli
Therapeutic targeting of CK2 in acute and chronic leukemias
published pages: 1-10, ISSN: 0887-6924, DOI: 10.1038/leu.2017.301
Leukemia 32/1 2019-06-06
2017 Mariana L. Oliveira, Padma Akkapeddi, Isabel Alcobia, Afonso R. Almeida, Bruno A. Cardoso, Rita Fragoso, Teresa L. Serafim, João T. Barata
From the outside, from within: Biological and therapeutic relevance of signal transduction in T-cell acute lymphoblastic leukemia
published pages: 10-25, ISSN: 0898-6568, DOI: 10.1016/j.cellsig.2017.06.011
Cellular Signalling 38 2019-06-06
2018 Mariana L. Oliveira, Padma Akkapeddi, Daniel Ribeiro, Alice Melão, João T. Barata
IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update
published pages: , ISSN: 2212-4926, DOI: 10.1016/j.jbior.2018.09.012
Advances in Biological Regulation 2019-04-18
2018 Daniel Ribeiro, Alice Melão, Ruben van Boxtel, Cristina I. Santos, Ana Silva, Milene C. Silva, Bruno A. Cardoso, Paul J. Coffer, João T. Barata
STAT5 is essential for IL-7–mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells
published pages: 2199-2213, ISSN: 2473-9529, DOI: 10.1182/bloodadvances.2018021063
Blood Advances 2/17 2019-04-18
2016 Alice Melão, Maureen Spit, Bruno A. Cardoso, João T. Barata
Optimal interleukin-7 receptor-mediated signaling, cell cycle progression and viability of T-cell acute lymphoblastic leukemia cells rely on casein kinase 2 activity
published pages: 1368-1379, ISSN: 0390-6078, DOI: 10.3324/haematol.2015.141143
Haematologica 101/11 2019-06-06

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IL7SIGNETURE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IL7SIGNETURE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

DISINTEGRATION (2019)

The Mass Politics of Disintegration

Read More  

SUExp (2018)

Strategic Uncertainty: An Experimental Investigation

Read More  

PROGRESS (2019)

The Enemy of the Good: Towards a Theory of Moral Progress

Read More